Yungjin Pharm. Co., Ltd. (003520.KS) KSC

1,946.00

+4(+0.21%)

Updated at September 29 09:27AM

Currency In KRW

Valuation

Market Cap363.59B
Enterprise Value425.23B
P/E Ratio-3,695.88
PEG Ratio-38.22
Price/Sales Ratio1.41
Price/Book Ratio3.61
Enterprise/Revenue1.67
Enterprise/EBITDA15.07

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0
Operating Margin0.03

Management Effectiveness

Return On Assets-0
Return On Equity-0

Income Statement

Revenue252.04B
Revenue/Share1,484.47
Gross Profit80.35B
EBITDA16.87B
Net Income1.23B
Diluted EPS6.74

Balance Sheet

Total Cash10.99B
Total Cash/Share64.88
Total Debt75.03B
Total Debt/Equity0.82
Current Ratio1.22
Book Value Per Share538.11

Price History

52-Week Change-17.54
52-Week High2,665
52-Week Low1,823
Moving Average 50 Days2,080.3
Moving Average 200 Days2,079.34

Statistics

Average Volume254,937
Shares Outstanding182.89M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor563:500
Last Split DateJune 18, 2010